Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

A Long Term Effects of a New Onset Psychosis after DBS Treated with Quetiapine in a Patient with Parkinson's Disease.

Piccoli S, Perini G, Pizzighello S, Vestri A, Ferri G, Toffanin T, Follador H, Martinuzzi A.

Psychiatry Investig. 2015 Jan;12(1):146-9. doi: 10.4306/pi.2015.12.1.146. Epub 2015 Jan 12.

2.

Surviving 10 years with deep brain stimulation for Parkinson's disease - a follow-up of 79 patients.

Bang Henriksen M, Johnsen EL, Sunde N, Vase A, Gjelstrup MC, Ostergaard K.

Eur J Neurol. 2014 Dec 9. doi: 10.1111/ene.12614. [Epub ahead of print]

PMID:
25492023
3.

Risks of common complications in deep brain stimulation surgery: management and avoidance.

Fenoy AJ, Simpson RK Jr.

J Neurosurg. 2014 Jan;120(1):132-9. doi: 10.3171/2013.10.JNS131225. Epub 2013 Nov 15.

PMID:
24236657
4.

Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.

Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C.

Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1. Erratum in: Lancet. 2014 Jul 5;384(9937):28.

PMID:
24183563
5.

Cerebral venous infarction: a potentially avoidable complication of deep brain stimulation surgery.

Morishita T, Okun MS, Burdick A, Jacobson CE 4th, Foote KD.

Neuromodulation. 2013 Sep-Oct;16(5):407-13; discussion 413. doi: 10.1111/ner.12052. Epub 2013 Jun 5.

6.

Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial.

Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM; CSP 468 Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1113-8. doi: 10.1136/jnnp-2012-304396. Epub 2013 May 10.

PMID:
23667214
7.

One-step tunneling of DBS extensions--a technical note.

Linhares P, Carvalho B, Vaz R.

Acta Neurochir (Wien). 2013 May;155(5):837-40; discussion 840. doi: 10.1007/s00701-013-1667-3. Epub 2013 Mar 7.

PMID:
23468039
8.

[Disinhibitory abnormal behavior induced by treatment of Parkinson disease].

Fujimoto K.

Brain Nerve. 2012 Apr;64(4):373-83. Review. Japanese.

PMID:
22481510
9.

A long-term follow-up of weight changes in subthalamic nucleus stimulated Parkinson's disease patients.

Foubert-Samier A, Maurice S, Hivert S, Guelh D, Rigalleau V, Burbaud P, Cuny E, Meissner W, Tison F.

Rev Neurol (Paris). 2012 Feb;168(2):173-6. doi: 10.1016/j.neurol.2011.04.006. Epub 2011 Oct 21.

PMID:
22019230
10.

Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Drapier S, Gillioz AS, Leray E, Péron J, Rouaud T, Marchand A, Vérin M.

Parkinsonism Relat Disord. 2012 Jan;18(1):40-4. doi: 10.1016/j.parkreldis.2011.08.010. Epub 2011 Sep 3.

PMID:
21890396
11.

Analysis of hemorrhagic risk factors during deep brain stimulation surgery for movement disorders: comparison of the circumferential paired and multiple electrode insertion methods.

Park JH, Chung SJ, Lee CS, Jeon SR.

Acta Neurochir (Wien). 2011 Aug;153(8):1573-8. doi: 10.1007/s00701-011-0997-2. Epub 2011 Apr 9.

PMID:
21476122
12.

Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.

Fernandez HH, Odin P.

Curr Med Res Opin. 2011 May;27(5):907-19. doi: 10.1185/03007995.2011.560146. Epub 2011 Feb 25. Review.

PMID:
21351823
13.

Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes.

Burdick AP, Fernandez HH, Okun MS, Chi YY, Jacobson C, Foote KD.

Neurosurg Focus. 2010 Aug;29(2):E4. doi: 10.3171/2010.4.FOCUS10100.

PMID:
20672921
14.

Gamma knife thalamotomy for disabling tremor: a blinded evaluation.

Lim SY, Hodaie M, Fallis M, Poon YY, Mazzella F, Moro E.

Arch Neurol. 2010 May;67(5):584-8. doi: 10.1001/archneurol.2010.69.

PMID:
20457958
15.

Effect of acute deep brain stimulation of the subthalamic nucleus on auditory event-related potentials in Parkinson's disease.

Naskar S, Sood SK, Goyal V.

Parkinsonism Relat Disord. 2010 May;16(4):256-60. doi: 10.1016/j.parkreldis.2009.12.006. Epub 2010 Feb 8.

PMID:
20116324
16.

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein J, Stoner G, Heemskerk J, Huang GD; CSP 468 Study Group.

JAMA. 2009 Jan 7;301(1):63-73. doi: 10.1001/jama.2008.929.

17.

Increase of frequency in deep brain stimulation relieves apraxia of eyelid opening in patients with Parkinson's disease: case report.

Strecker K, Meixensberger J, Schwarz J, Winkler D.

Neurosurgery. 2008 Dec;63(6):E1204; discussion E1204. doi: 10.1227/01.NEU.0000335781.27643.5B.

PMID:
19057285
18.

Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up.

Gan J, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Mollion H, Benatru I, Henry E, Broussolle E, Thobois S.

J Neurol. 2007 Jan;254(1):99-106. Epub 2007 Feb 14.

PMID:
17508144
19.

Deep brain stimulation for Parkinson's disease: the Vanderbilt University Medical Center experience, 1998-2004.

Gill CE, Konrad PE, Davis TL, Charles D.

Tenn Med. 2007 Apr;100(4):45-7.

PMID:
17474384
20.

Operative and hardware complications of deep brain stimulation for movement disorders.

Paluzzi A, Belli A, Bain P, Liu X, Aziz TM.

Br J Neurosurg. 2006 Oct;20(5):290-5.

PMID:
17129876
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk